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I.  General Procedures. Unless otherwise stated, reactions were performed under a nitrogen atmosphere using 
freshly dried solvents. Tetrahydrofuran (THF), methylene chloride (CH2Cl2), acetonitrile (MeCN), 
dimethylformamide (DMF), and toluene (PhMe) were dried by passing through activated alumina columns. 
Triethylamine (Et3N) and methanol (MeOH) were distilled over calcium hydride prior to use. Unless otherwise 
stated, chemicals and reagents were used as received. Copper(I) trifluoromethanesulfonate toluene complex 
[(CuOTf)2•PhMe] was purchased from Sigma-Aldrich (99.9% trace metal basis) or Alfa-Aesar (98%). All 
reactions were monitored by LCMS on an Agilent 1290 Series LCMS using an Eclipse Plus C18 column (RRHD 
1.8 µm, 2.1 x 50 mm, 11,072 plates) and electrospray ionization (ESI), or by thin-layer chromatography using 
EMD/Merck silica gel 60 F254 pre-coated plates (0.25 mm) and were visualized by UV, p-anisaldehyde, 
potassium permanganate (KMnO4), or cerium ammonium molybdate (CAM) staining. Flash column 
chromatography was performed as described by Still et al.1 using silica gel (partical size 0.032-0.063). Optical 
rotations were measured on a Jasco P-2000 polarimeter using a 100 mm path-length cell at 589 nm. 1H and 13C 
NMR spectra were recorded on a Varian 400 MR (at 400 MHz and 101 MHz, respectively), a Varian Inova 500 
(at 500 MHz and 126 MHz, respectively), or a Varian Inova 600 (at 600 MHz and 150 MHz, respectively), and 
are reported relative to internal CHCl3 (1H, δ = 7.26), CD3OD (1H, δ = 3.31), or DMSO (1H, δ = 2.50), and CDCl3 
(13C, δ = 77.0), CD3OD (13C, δ = 49.0), or DMSO (13C, δ = 40.0). Data for 1H NMR spectra are reported as 
follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration). Multiplicity and qualifier 
abbreviations are as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, app = 
apparent. IR spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in frequency of 
absorption (cm–1). HRMS were acquired using an Agilent 6200 Series TOF with an Agilent G1978A Multimode 
source in electrospray ionization (ESI), atmospheric pressure chemical ionization (APCI), or mixed (MM) 
ionization mode. LRMS were acquired using an Agilent 1290 Series LCMS using an Eclipse Plus C18 column 
(RRHD 1.8 µm, 2.1 x 50 mm, 11,072 plates) and electrospray ionization (ESI). 
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II.  Preparation of α-Diimine ligands. 
 
 α-Diimine ligands were prepared following literature precedent by Bercaw et al. 1 MesDABMe (L7) and 
tBuDABMe (L6) were readily prepared on greater than 40 gram scale in comparable yields to those reported in the 
literature. Ligands were thoroughly dried under high-vacuum (< 1.0 mTorr) at 50 °C for 4 hours and stored in a 
glovebox under inert atmosphere. 
 
III.  Preparation of Diketopiperazine Substrates 
 
The preparation of diketopiperazines 4a-f have been previously prepared in the literature. Diketopiperazine 
substrates 4d and 4e were prepared according to known literature procedures. 2  Improved yields were obtained 
for substrates 4a-4c using an analogous procedure as reported by Movassaghi et al.3   
 
General Procedure (I) for the Synthesis of Diketopiperazine Substrates: 
 
 To a solution of L-tryptophan methyl ester hydrochloride (1.0 equiv) in CH2Cl2 (0.1 M) at 0 °C was 
added Et3N (4.5 equiv) dropwise.  HOBt•H2O (1.5 equiv) and Boc-amino acid (2.0 equiv) were sequentially 
added and stirred vigorously.  Once homogenous, EDC•HCl (1.5 equiv) was added in a single portion and the 
solution allowed to warm to 23 °C.  The reaction was stirred for 15 hours, at which time it was quenched by the 
addition of 1N HCl, and the aqueous layer extracted with CH2Cl2 (2 x). The combined organics were then washed 
with saturated aqueous NaHCO3, and the aqueous layer back extracted with CH2Cl2 (2 x). The organics were 
pooled, then dried over Na2SO4, filtered, and concentrated in vacuo. The resulting oil/foam was subsequently 
dissolved in CH2Cl2 (0.2 M), and cooled to 0 °C. TFA (1.5 mL/5 mL CH2Cl2) was added dropwise, then the 
solution was warmed to 23 °C and stirred for 2 h. The mixture was concentrated in vacuo and the resulting 
viscous residue dissolved in methanol (0.25 M), and cooled to 0°C. Ammonium hydroxide (28–30% in H2O, 1 
mL/ 6 mL MeOH) was then added dropwise and the reaction mixture allowed to warm to 23 °C and stirred for 24 
h. The resulting suspension was cooled to 0 °C, and the fine white precipitate was filtered and rinsed with cold 
methanol.  The white solid is then crushed and dried under high vacuum (< 1 mTorr) at 50 °C for a minimum of 2 
h.  
 
Cyclo-(L)-Trp-(L)-Phe (4a) 
 Prepared from L-tryptophan methyl ester hydrochloride following General 
Procedure I on 19.6 mmol scale. The crude reaction mixture was filtered to yield 5.8 
                                                
1 Zhong, H. A.; Labinger, J. A.; Bercaw, J. E. J. Am. Chem. Soc. 2002, 124, 1378. 
2 Cabarallero, E; Avendano, C; Menendez, J. C. Tetrahedron-Asymmetr. 1998, 17, 3025. 
3 Kim, J.; Movassaghi, M. J. Am. Chem. Soc. 2011, 133, 14940. 
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g (89% yield) of 4a as a white solid.  Spectral data matches that reported in the literature.4 
 
Cyclo-(L)-Trp-(L)-Ala (4b) 
 Prepared from L-tryptophan methyl ester hydrochloride following General 
Procedure I on 9.8 mmol scale.  The crude reaction mixture was filtered to yield 2.3 
g (92% yield) of 4b as a white solid.  Spectral data matches that reported in the 
literature.5 
 
 
Cyclo-(L)-Trp-(D)-Ala (4c) 
 Prepared from L-tryptophan methyl ester hydrochloride following General 
Procedure I on 7.9 mmol scale.  The crude reaction mixture was filtered to yield 1.8 
g (89% yield) of 4c as a white solid.  Spectral data matches that reported in the 
literature.4 
 
 
Large Scale Preparation of Cyclo-(L)-Trp-(L)-Pro (4f): 
 
 To a solution of L-proline methyl ester hydrochloride (11.0 g, 66.6 mmol, 1.00 
equiv) in CH2Cl2 (700 mL) at 0 °C was added triethylamine (32.5 mL, 233 mmol, 3.50 
equiv) dropwise by addition funnel. N-hydroxybenzotriazole monohydrate (15.3, 100 
mmol, 1.50 equiv) and Boc-(L)-tryptophan (31.8 g, 100 mmol, 1.50 equiv) were then 
added successively. After 10 minutes, EDC•HCl (19.2 g, 100 mmol, 1.50 equiv) was added in a single portion and 
the mixture allowed to warm to 23 °C over 2.0 hours. After 20 hours, the solution was quenched by the addition 
of 1N HCl (1.0 L), and the aqueous layer extracted with CH2Cl2 (2 x 150 mL). The combined organics were then 
washed with saturated aqueous NaHCO3 (1.0 L), and the aqueous layer back extracted with CH2Cl2 (200 mL). 
The combined organics were then dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. The 
resulting white foam was then dissolved in CH2Cl2 (200 mL), and trifluoroacetic acid (60 mL) added dropwise by 
addition funnel. After 2 h, the solution was concentrated in vacuo and the viscous residue dissolved in methanol 
(900 mL) and cooled to 0 °C. Ammonium hydroxide (28 to 30% in H2O, 35.0 mL) was added dropwise by 
addition funnel. The solution was then stirred for 14 hours, concentrated in vacuo, and redissolved in CH2Cl2 (1.0 
L). The solution was next washed with H2O (3 x 500 mL), and the aqueous layer back extracted with CH2Cl2 (250 
mL). The organic layers were then dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. The residue 
was dissolved in MeOH (200 mL) and the solution cooled to 0 °C. After 20 minutes, the resulting white 
precipitate was collected. The filtrate was then concentrated to 100 mL and recooled to 0 °C, and a second crop of 
                                                
4 Tullberg, M.; Grotli, M.; Luthman, K. Tetrahedron. 2006,  62, 7484. 
5 Caballero, E.; Avendano, C.; Menendez, J. C. Tetrahedron-Asymmetr. 1998, 9, 967. 
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precipitate collected. The process was repeated a third time to collect a third crop of product. The resulting 
precipitates were combined, powdered, and dried under high vacuum at 50 °C for 12 hours to afford analytically 
pure cyclo-L-Pro-L-Trp as a white solid (12.4 g, 43.8 mmol, 66% yield).  Spectral data matches that reported in 
the literature.6  
 
Preparation of Trifluoroacetyltryptophan methyl carboxamide (7): 
 
To (L)-Tryptophan methyl ester hydrochloride (5.84 g, 22.9 mmol) was added 
methylamine (33% solution in EtOH, 50 mL). The mixture was stirred for 48 h at 20 
°C, then concentrated in vacuo, and the mixture co-evaporated with CH2Cl2 (50 mL), 
then Et2O (3 x 100 mL), sequentially to afford a white solid. The solid was then 
suspended in anhydrous CH2Cl2 (250 mL), and Et3N (9.6 mL, 68.7 mmol, 3.0 equiv) was added dropwise by 
syringe at 20 °C. The resulting mixture was then cooled to 0 °C, and TFAA (3.23 mL, 22.9 mmol, 1.00 equiv) 
added dropwise by syringe. After 24 hours, the reaction was quenched with 1N HCl (200 mL), extracted with 
CH2Cl2 (200 mL), dried over Na2SO4, filtered and concentrated.  The residue was then dissolved in EtOAc (250 
mL), and filtered through a short plug of silica gel, and the filter cake washed with additional EtOAc (250 mL). 
The filtrate was then concentrated, and the resulting yellow solid was treated with Et2O/pentane to afford 7 as a 
white, amorphous powder (2.97 g, 42% yield). 1H NMR (500 MHz, DMSO-d6) 10.82 (d, J = 0.9 Hz, 1H), 9.61 (d, 
J = 8.2 Hz, 1H), 8.21 (q, J = 4.3 Hz, 1H), 7.65 (d, J = 7.9 Hz, 1H), 7.33 (d, J = 8.1 Hz, 1H), 7.13 (d, J = 2.3 Hz, 
1H), 7.10 – 7.04 (m, 1H), 6.99 (ddd, J = 7.9, 7.1, 1.0 Hz, 1H), 4.52 (ddd, J = 9.9, 8.5, 4.8 Hz, 1H), 3.20 (dd, J = 
14.6, 4.6 Hz, 1H), 3.08 (dd, J = 14.6, 10.0 Hz, 1H), 2.62 (d, J = 4.6 Hz, 3H); 13C NMR (126 MHz, DMSO-d6) 
170.3, 156.2 (q, JC-F = 36.4 Hz), 136.1, 127.1, 123.7, 121.0, 118.4, 118.3, 115.8 (q, JC-F = 288.2 Hz), 111.4, 109.7, 
54.3, 27.2, 25.7; FTIR (NaCl, thin film): 3277, 1700, 1696, 1653, 1636, 1560, 1347, 1185; [α]D25 = +8.53 (c = 
0.44, CHCl3); LRMS (EI+) calc’d [M+H]+ 314.1, found 314.1. 
 
  
                                                
6 Caballero, E.; Avedano, C.; Menendez, J. C. J. Org. Chem. 2003, 68, 6944. 
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IV.  Preparation of Diaryliodonium Salts 
 
The following diaryliodonium salts were prepared following known procedures: diphenyliodonium 
tetrafluoroborate, 7  diphenyliodonium hexafluoroarsentate, 8  diphenyliodonium triflate, 9  bis-p-tolyliodonium 
triflate, 9  and bis-p-methoxyiodonium triflate.10 Diphenyliodonium hexafluorophosphate was purchased from 
Alfa-Aesar. m-CPBA (Sigma-Aldrich, <77%) was dried under high vacuum (< 1 mTorr) at 23 °C for 4 hours as 
reported by Oloffson and coworkers.11 
 
Preparation of 2-iodo-p-xylene diacetate (SI-1): 
 
To a solution of 2-iodo-1,4-dimethylbenzene (11.6 g, 50.0 mmol, 1.00 equiv) in AcOH (1.0 L) 
at 50 °C was added NaBO3•4H2O (84.7 mmol, 0.55 mmol, 11.0 equiv) portion wise over 30 
minutes. The solution was vigorously stirred at 50 °C for 5 hours, then cooled to ambient 
temperature and diluted with H2O (500 mL) and extracted with CH2Cl2 (3 x 500 mL). The 
combined organics were then washed with water (3 x 500 mL), dried over anhydrous sodium sulfate, filtered, and 
concentrated in vacuo. The crude residue was suspended in a minimum of Et2O, then triturated with hexanes and 
the precipitate collected by vacuum filtration. 2-Iodo-p-xylene diacetate was obtained as a white, crystalline solid 
(14.0 g, 40.0 mmol, 80% yield). Spectral data obtained match that previously reported,12 1H and 13C NMR data is 
reported for convenience. 1H NMR (500 MHz, CDCl3) δ 7.97 (d, J = 1.2 Hz, 1H), 7.37 (d, J = 7.8 Hz, 1H), 7.30 
(dd, J = 7.8, 1.2 Hz, 1H), 2.65 (s, 3H), 2.36 (s, 3H), 1.97 (s, 6H); 13C NMR (126 MHz, CDCl3): δ 176.3, 138.5, 
137.3, 137.3, 133.5, 130.4, 126.8, 24.9, 20.6, 20.2. 
 
General Procedure II7 
To a solution of iodoarene in CH2Cl2 (0.25 M) was added mCPBA (1.1 equiv), and BF3•OEt2 (2.5 equiv). The 
solution was stirred for 45 minutes, then the solution cooled to 0 °C in a dry ice corresponding aryl boronic acid 
(1.00 equiv) added a solid in a single portion. The solution was stirred for 15 minutes, then warmed to room 
temperature and stirring continued for 45 minutes. The solution was then recooled to 0 °C and TfOH (2.00 equiv) 
added dropwise via syringe. The solution was stirred for 5 minutes at 0 °C, then warmed to room temperature and 
concentrated under reduced pressure. The resulting solution was then filtered through a plug of silica gel, eluting 
with 5% MeOH/CH2Cl2, the filtrate concentrated, and the residue triturated from Et2O to afford pure 
diaryliodonium triflate, typically as a white, crystalline solid. 
 
                                                
7 Bielawski, M.; Aili, D.; Olofsson, B. J. Org. Chem. 2008, 73, 4602. 
8 Zhu, S.; MacMillan, D. W. C. J. Am. Chem. Soc. 2012, 134, 10815. 
9 Bielawski, M.; Zhu; M.; Olofsson, B. Adv. Synth. Catal. 2007, 349, 2610. 
10 Zhu, M,; Jalalian N.; Olofsson, B. Synlett 2008, 4, 592. 
11 Bielawski, M.; Olofsson, B. Org. Synth. 2009, 86, 308.  
12 Sharefkin, J. G.; Saltzman, H.; Anal. Chem., 1963, 35, 1428. 
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General Procedure III 
To a solution of aryl boronic acid (1.00 equiv) in CH2Cl2 (0.25 M) at 0 °C was added BF3•OEt2 (1.1 equiv) 
dropwise by syringe. The solution was stirred for 15 minutes, then a solution of iodoxylene diacetate (1.00 equiv) 
in CH2Cl2 (0.5 M) added dropwise by cannula transfer over 15 minutes. The solution was slowly warmed to 23 °C 
over 1 h, then recooled to 0 °C and TfOH (2.00 equiv) added dropwise via syringe. The solution was stirred for 5 
minutes at 0 °C, then warmed to room temperature and concentrated under reduced pressure. The resulting 
solution was then filtered through a plug of silica gel, eluting with 5 % MeOH/CH2Cl2, the filtrate concentrated, 
and the residue triturated from Et2O to afford pure diaryliodonium triflate salt, typically as a white, crystalline 
solid. 
 
Di-(3-tolyl)iodonium triflate (SI-2) 
 Prepared by General Procedure II from 3-methylphenyl boronic acid and 3-
methyliodobenzene on 5.00 mmol scale. Trituration from Et2O afforded SI-2 as a 
white, crystalline solid (1.54 g, 3.36 mmol, 67% yield). 1H NMR (500 MHz, DMSO-
d6) δ 8.10 (td, J = 1.8, 0.9 Hz, 2H), 8.04 (ddt, J = 7.9, 1.8, 0.9 Hz, 2H), 7.48 (ddt, J = 
7.7, 1.8, 1.0 Hz, 2H), 7.41 (t, J = 7.8 Hz, 2H), 2.34 (d, J = 0.8 Hz, 6H); 13C NMR (126 MHz, DMSO-d6) δ 142.3, 
135.78, 133.2, 132.7, 131.9, 116.6, 21.2; FTIR (NaCl, thin film): 3744, 3675, 1596, 1259, 1172, 1036, 1026 cm-1; 
LRMS (EI+) calc’d [M–OTf]+ 309.1, found 309.0. 
 
Di-(3,5-dimethylphenyl)iodonium triflate (SI-3) 
Prepared by General Procedure II from 3,5-dimethyliodobenzene and 3,5-
dimethylphenylboronic acid on 10.0 mmol scale. Trituration from Et2O afforded SI-
3 as a white, crystalline solid (3.72 g, 7.65 mmol, 77% yield). 1H NMR (500 MHz, 
DMSO-d6) δ 7.88 (dt, J = 1.5, 0.8 Hz, 4H), 7.30 (tt, J = 1.5, 0.8 Hz, 2H), 2.30 (d, J = 
0.9 Hz, 12H); 13C NMR (500 MHz, DMSO-d6): δ 141.9, 133.9, 132.9, 116.2, 21.1; FTIR (NaCl, thin film):  1599, 
1558, 1451, 1381, 1243, 1221, 1171, 1154, 1026 cm-1; LRMS (EI+) calc’d [M–OTf]+ 337.2, found 337.2. 
 
(2-naphthyl)(p-xylyl)iodonium triflate (SI-4) 
Prepared by General Procedure III from 2-naphthyl boronic acid on 5.00 mmol 
scale. Trituration from Et2O afforded SI-4 as a white, crystalline solid (2.15 g, 4.23 
mmol, 85% yield). 1H NMR (500 MHz, DMSO-d6) δ 8.93 (d, J = 1.9 Hz, 1H), 8.29 (dd, 
J = 1.7, 0.9 Hz, 1H), 8.18 (dd, J = 8.8, 1.9 Hz, 1H), 8.10 – 7.99 (m, 4H), 7.73 – 7.66 (m, 
2H), 7.43 (d, J = 7.8 Hz, 1H), 7.38 (ddd, J = 7.7, 1.7, 0.8 Hz, 1H), 2.61 (s, 3H), 2.31 (s, 3H); 13C NMR (500 MHz, 
DMSO-d6): δ 139.6, 137.9, 137.6, 136.5, 134.4, 133.9, 133.8, 132.00, 131.5, 130.6, 129.4, 128.6, 128.6, 128.4, 
I
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121.6, 113.0, 25.0, 20.5; FTIR (NaCl, thin film):  3670, 3588, 1653, 1635, 1490, 1347, 1259, 1172, 1036, 1024 
cm-1; LRMS (EI+) calc’d [M–OTf]+ 359.0, found 359.0. 
 
(3-bromophenyl)(p-xylyl)iodonium triflate (SI-5) 
Prepared by General Procedure III from 3-bromophenyl boronic acid on 5.00 
mmol scale. Trituration from Et2O afforded SI-5 as a white, crystalline solid (1.33 g, 2.48 
mmol, 50% yield). 1H NMR (500 MHz, DMSO-d6) δ 8.53 (dd, J = 1.8, 1.8 Hz, 1H), 8.28 
(dd, J = 1.8, 0.9 Hz, 1H), 8.18 (ddd, J = 8.0, 1.8, 0.9 Hz, 1H), 7.85 (ddd, J = 8.1, 1.9, 0.9 
Hz, 1H), 7.51 - 7.42 (m, 2H), 7.44 - 7.38 (m, 1H), 2.57 (s, 3H), 2.32 (s, 3H); 13C NMR 
(500 MHz, DMSO-d6): δ 139.2, 137.5, 137.1, 136.7, 134.9, 133.9, 133.6, 133.5, 131.1, 123.3, 121.2, 116.1, 24.5, 
20.0; FTIR (NaCl, thin film):  3074, 1569, 1554, 1490, 1456, 1275, 1242, 1170, 1025 cm-1; LRMS (EI+) calc’d 
[M–OTf]+ 388.1, found 388.9. 
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V.  Optimization of Reaction Parameters 
 
Optimization Procedure – In a glovebox, (CuOTf)2•PhMe (20.7 mg, 0.040 mmol), and ligand (0.088 
mmol) were dissolved in anhydrous CH2Cl2 (4.0 mL). The solution was stirred vigorously for 1.0 h, filtered 
through a plug of cotton and removed from the glovebox. A portion of the solution (1.00 mL, 0.020 mmol, 20 mol 
% in Cu) was added to an oven-dried, 1-dram vial containing diketopiperazine (0.100 mmol) and diaryliodonium 
salt (0.110 mmol). The solution was stirred at 23 °C (care was taken not to exceed 25 °C) for 24 h, then quenched 
by the addition of concentrated ammonia (28–30% in H2O, 1.0 mL). After 5 minutes, the mixture was diluted with 
EtOAc (30 mL) and washed with a mixture water (20 mL) and brine (20 mL). The aqueous layer was then back 
extracted with EtOAc (2 x 10 mL) and the combined organics dried over anhydrous MgSO4, filtered, and 
concentrated in vacuo to afford a solid residue. 
 
The residue was then dissolved in a standard solution of maleic acid in DMSO-d6, and the solution analyzed for 
yield, C3:C2 ratio, and dr. NMR yields were obtained via careful integration against the standard. 
 
Preparation of minor diastereomer SI-6 
To an oven dried vial was added diketopiperazine 4a (33 mgs, 0.1 mmol), diaryliodonium 
hexafluorophosphate (47 mgs, 0.11 mmol) and (CuOTf)2•PhMe (5.2 mgs, 0.01 mmol).  
The solids were dissolved in 1 mL CH2Cl2 and the reaction was allowed to stir for 24 
hours, then quenched by the addition of 1 mL NH4OH.  The mixture was diluted with 
EtOAc and extracted with EtOAc (2 X 10 mL).  The organic layers were combined, dried 
over Na2SO4, filtered and concentrated. The minor diastereomer was purified from the crude residue by silica gel 
chromatography (50% hexanes, 47.5% ethyl acetate, 2.5% methanol) to afford SI-6 as a white solid.  1H NMR 
(500 MHz, CDCl3) 7.30 – 7.27 (m, 2H), 7.26 – 7.22 (m, 3H), 7.22 – 7.16 (m, 3H), 7.15 – 7.09 (m, 2H), 7.04 (ddd, 
J = 7.7, 7.7, 1.3 Hz, 1H), 6.88 – 6.83 (m, 1H), 6.67 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.61 (d, J = 7.8 Hz, 1H), 5.77 
(s, 1H), 5.69 (d, J = 9.3 Hz, 1H), 4.40 – 4.32 (m, 1H), 4.16 (ddd, J = 10.5, 3.8, 1.3 Hz, 1H), 3.51 (dd, J = 14.5, 3.8 
Hz, 1H), 3.15 (dd, J = 13.7, 7.3 Hz, 1H), 2.69 (ddd, J = 16.6, 14.1, 10.2 Hz, 2H); 13C NMR (126 MHz, CDCl3) 
168.8, 166.8, 147.2, 142.3, 135.6, 133.3, 129.2, 128.9, 128.8, 128.6, 127.5, 127.3, 126.5, 124.1, 119.6, 109.6, 
85.5, 59.2, 58.6, 56.1, 38.6, 36.2; FTIR (NaCl, thin film): 3306, 3058, 2929, 1674, 1607, 1482, 1447, 1318, 1223, 
1071 cm-1; [α]D25 = –329 (c = 0.31, CHCl3); LRMS (EI+) calc’d for [M+H]+ 410.2, found 410.2. 
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VI.  Substrate Scope – Characterization Data 
 
General Procedure IV:  Tryptophan Arylation 
 
Catalyst Preparation – In a glovebox, copper(I)trifluoromethanesulfonate toluene complex (0.10 equiv) and alpha-
diimine-ligand (0.22 equiv) were dissolved in anhydrous CH2Cl2 (0.1 M in Cu). The solution was vigorously 
stirred for 1.0 hour, and then filtered through a plug of cotton.13 The solution was then removed from the 
glovebox for immediate use. 
 
Arylation Reaction – A flame-dried flask containing a magnetic stirbar was charged with tryptophan substrate 
(0.300 mmol, 1.00 equiv) and diaryliodonium salt (0.330 mmol, 1.1 equiv), then equipped with a rubber septum. 
To the solids was added the freshly-prepared Cu-catalyst solution prepared above (3.00 mL, 0.030 mmol, 20 mol 
%) and the solution vigorously stirred at 20 °C. After the time indicated below, the solution was quenched with 
aqueous ammonia (3.00 mL of a 27-33% solution in H2O) and stirred for 5 minutes. The reaction was then diluted 
with EtOAc (30 mL) and washed with a mixture of H2O (30 mL) and brine (30 mL). The aqueous portion was 
back extracted with EtOAc (2 x 10 mL) and the combined organics dried over anhydrous MgSO4, filtered, and 
concentrated in vacuo. The crude residue was purified by column chromatography on silica gel to afford pure aryl 
pyrroloindoline product, typically as either a white, amorphous powder or a white foam. 
 
Pyrroloindoline 5a 
Prepared following General Procedure IV using MesDABMe and diphenyliodonium 
triflate.  The crude residue was purified by silica gel chromatography (50% hexanes, 
47.5% ethyl acetate, 2.5% methanol) to afford 5a as a white solid (104.0 mg, 0.254 
mmol, 85% yield). 1H NMR (500 MHz, CDCl3) δ 7.38 – 7.31 (m, 6H), 7.28 (ddd, J 
= 5.1, 2.3, 2.3 Hz, 2H), 7.20 (d, J = 7.0 Hz, 2H), 7.12 (ddd, J = 7.7, 7.7, 1.2 Hz, 1H), 
6.97 – 6.89 (m, 1H), 6.75 (dd, J = 7.5, 7.5 Hz, 1H), 6.69 (d, J = 7.9 Hz, 1H), 5.85 (s, 1H), 5.60 (s, 1H), 4.44 (dd, J 
= 8.4, 8.4 Hz, 1H), 4.24 (ddd, J = 10.7, 3.7, 1.1 Hz, 1H), 3.61 (dd, J = 14.5, 3.7 Hz, 1H), 3.23 (dd, J = 13.7, 7.4 
Hz, 1H), 2.77 (ddd, J = 13.6, 10.2, 2.2 Hz, 2H); 13C NMR (126 MHz, CDCl3) δ 168.8, 166.8, 147.1, 142.3, 135.6, 
133.3, 129.3, 128.9, 128.9, 128.7, 127.6, 127.6, 126.5, 124.2, 119.7, 109.7, 85.5, 59.3, 58.7, 56.2, 38.6, 36.3; 
FTIR (NaCl, thin film): 3315, 3087, 3052, 3027, 2928, 2849, 1676, 1605, 1498, 1407, 1348, 1306, 1261, 1221 
cm-1; [α]D25 = +113 (c = 1.8, CHCl3); LRMS (EI+) calc’d [M+H]+ 410.2, found 410.2.  
 
  
                                                
13 Filtering the catalyst solution was found to improve the overall selectivity, reactivity, and reproducibility of the reaction.  
N
H
N NH
O
O
H
H
Ph
5a
 S12 
Pyrroloindoline 5b 
Prepared following General Procedure IV using MesDABMe and diphenyliodonium triflate 
for 24 h. Reaction was run with additional CH2Cl2 (3.00 mL) for solubility. The crude 
residue was purified by silica gel chromatography (20% hexanes : 77.5% ethyl acetate: 
2.5% methanol) to afford 5b as a white solid (66.2 mg, 0.199 mmol, 66% yield). 1H 
NMR (500 MHz, CDCl3) δ 7.40 – 7.32 (m, 4H), 7.32 – 7.26 (m, 1H), 7.09 (dd, J = 7.7, 
7.7 Hz, 1H), 6.94 (d, J = 7.5 Hz, 1H), 6.74 (d, J = 7.5, 7.5 Hz, 1H), 6.65 (d, J = 7.8 Hz, 1H), 5.82 (d, J = 8.3 Hz, 
1H), 5.79 (s, 1H), 4.48 (dd, J = 8.3, 8.3 Hz, 1H), 4.15 – 4.05 (m, 1H), 3.21 (dd, J = 13.8, 7.6 Hz, 1H), 2.84 (dd, J 
= 13.8, 9.3 Hz, 1H), 1.46 (d, J = 6.8 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 169.3, 167.9, 147.2, 142.3, 133.2, 
128.9, 128.7, 127.4, 126.5, 124.2, 119.7, 109.8, 85.5, 59.4, 59.0, 51.3, 38.3, 15.7; FTIR (NaCl, thin film): 3255, 
2928, 2849, 1669, 1653, 1486, 1419, 1219 cm-1; [α]D25 = +158 (c = 0.85, CHCl3); LRMS (EI+) calc’d for [M+H]+ 
334.2, found 334.1. 
 
Pyrroloindoline 5c 
Prepared following General Procedure IV using MesDABMe and diphenyliodonium 
triflate for 24 h. Reaction was run with additional CH2Cl2 (3.00 mL) for solubility. The 
crude residue was purified by silica gel chromatography (77.5% ethyl acetate, 20% 
hexanes, 2.5% methanol) to afford 5c as a white solid (49.5 mg, 0.149 mmol, 50% 
yield). 1H NMR (500 MHz, CDCl3) δ 7.40 – 7.32 (m, 4H), 7.31 – 7.26 (m, 1H), 7.09 
(ddd, J = 7.6, 7.6, 1.0 Hz, 1H), 7.01 (d, J = 3.8 Hz, 1H), 6.88 (dd, J = 7.4, 0.5 Hz, 1H), 6.72 (dd, J = 7.4, 7.4 Hz, 
1H), 6.65 (d, J = 7.9 Hz, 1H), 5.84 (d, J = 3.0 Hz, 1H), 5.54 (d, J = 3.0 Hz, 1H), 4.43 (dd, J = 10.6, 7.0 Hz, 1H), 
4.01 (qd, J = 7.2, 4.2 Hz, 1H), 3.29 (dd, J = 13.7, 7.0 Hz, 1H), 2.65 (dd, J = 13.7, 10.7 Hz, 1H), 1.46 (d, J = 7.2 
Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 168.8, 167.9, 147.1, 142.2, 133.6, 128.9, 128.7, 127.3, 126.7, 124.0, 
119.5, 109.6, 86.0, 58.8, 57.2, 53.6, 39.4, 19.8; FTIR (NaCl, thin film): 3275, 3042, 2913, 1684, 1652, 1437, 
1308, 1266, 1221 cm-1; [α]D25 = +119 (c = 1.1, CHCl3); LRMS (EI+) calc’d for [M+H]+ 334.2, found 334.1 
 
Pyrroloindoline 5d 
Prepared following General Procedure IV using MesDABMe and diphenyliodonium triflate 
for 24 h. Reaction was run with additional CH2Cl2 (3.00 mL) for solubility.  The crude 
residue was purified by silica gel chromatography (77.5% ethyl acetate, 20% hexane, 
2.5% methanol) to afford 5d as a white solid (61.5 mg, 0.193 mmol, 64% yield). 
1H NMR (500 MHz, CDCl3) δ 7.39 – 7.30 (m, 4H), 7.29 – 7.26 (m, 1H), 7.09 (ddd, J = 
7.7, 7.7, 1.3 Hz, 1H), 6.96 – 6.90 (m, 1H), 6.86 (d, J = 4.2 Hz, 1H), 6.73 (ddd, J = 7.5, 
7.5, 1.0 Hz, 1H), 6.65 (d, J = 7.8 Hz, 1H), 5.81 (s, 1H), 4.43 (dd, J = 8.5, 8.5 Hz, 1H), 4.02 (dd, J = 17.0, 1.6 Hz, 
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1H), 3.85 (dd, J = 17.0, 4.6 Hz, 1H), 3.23 (dd, J = 13.7, 7.4 Hz, 1H), 2.77 (dd, J = 13.8, 9.8 Hz, 1H); 13C NMR 
(126 MHz, CDCl3) δ 169.4, 165.2, 147.1, 142.3, 133.3, 128.9, 128.7, 127.3, 126.5, 124.2, 119.7, 109.8, 85.4, 
59.2, 58.0, 46.7, 38.7; FTIR (NaCl, thin film): 3280, 3047, 2928, 2854, 1674, 1602, 1483, 1441, 1310, 1263, 
1219, 1155 cm-1; [α]D25 = +80.2 (c = 0.59, CHCl3); LRMS (EI+) calc’d for [M+H]+ 320.1, found 320.1. 
 
Pyrroloindoline 5e 
Prepared following General Procedure IV using MesDABMe and diphenyliodonium triflate for 24 h. The 
crude residue was purified by silica gel chromatography (20% hexanes, 77.5% ethyl acetate, 2.5% methanol) to 
afford 5e as a white solid (55.5 mg, 0b.154 mmol, 51% yield). 
1H NMR (500 MHz, CDCl3) δ 7.39 – 7.31 (m, 4H), 7.30 – 7.26 (m, 1H), 7.11 – 7.06 
(m, 1H), 6.96 – 6.92 (m, 1H), 6.73 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.66 – 6.62 (m, 
1H), 5.87 (s, 1H), 5.80 (d, J = 2.6 Hz, 1H), 5.44 (d, J = 2.4 Hz, 1H), 4.47 – 4.39 (m, 
1H), 3.91 – 3.87 (m, 1H), 3.23 (dd, J = 13.7, 7.4 Hz, 1H), 2.79 (dd, J = 13.7, 9.7 Hz, 
1H), 2.60 (heptd, J = 7.1, 2.6 Hz, 1H), 1.05 (d, J = 7.2 Hz, 3H), 0.87 (d, J = 6.8 Hz, 
3H); 13C NMR (126 MHz, CDCl3) δ 169.4, 166.7, 147.3, 142.4, 133.3, 128.9, 128.6, 
127.3, 126.5, 124.3, 119.6, 109.5, 85.5, 60.4, 59.1, 58.2, 38.8, 28.4, 19.3, 16.0; FTIR (NaCl, thin film): 3292, 
2964, 1669, 1609, 1483, 1465, 1419, 1347, 1291, 1222 cm-1; [α]D25 = +107 (c = 0.52, CHCl3); LRMS (EI+) calc’d 
for [M+H]+ 362.2, found 362.2. 
 
Pyrroloindoline 5f 
Prepared following General Procedure IV using 40 mol % t-BuDABMe and 
diphenyliodonium hexafluorophosphate for 4 h. The crude residue was purified by 
silica gel chromatography (77.5% ethyl acetate, 20% hexanes, 2.5% methanol) to 
afford 5f as a white solid (76.6 mg, 0.213 mmol, 71% yield). 
1H NMR (500 MHz, CDCl3) δ 7.38 - 7.34 (m, 4H), 7.31 - 7.27 (m, 1H), 7.08 (ddd, J = 
7.9, 7.5, 1.3 Hz, 1H), 6.91 (ddd, J = 7.5, 1.3, 0.6 Hz, 1H), 6.73 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.67 - 6.61 (m, 
1H), 5.83 (s, 1H), 5.36 (s, 1H), 4.55 - 4.48 (m, 1H), 4.14 (ddd, J = 9.1, 7.3, 1.6 Hz, 1H), 3.54 - 3.46 (m, 2H), 3.21 
(dd, J = 13.9, 7.4 Hz, 1H), 2.81 (dd, J = 13.9, 9.8 Hz, 1H), 2.31 (dddd, J = 12.8, 7.0, 7.0, 3.4 Hz, 1H), 2.17 (dddd, 
J = 12.9, 10.7, 9.2, 7.2 Hz, 1H), 2.07 - 1.96 (m, 1H), 1.90 (dddd, J = 14.9, 6.8, 4.0, 1.9 Hz, 1H); 13C NMR (126 
MHz, CDCl3) δ 167.9, 165.7, 147.0, 142.3, 133.6, 128.8, 128.8, 128.6, 127.3, 126.7, 124.1, 119.7, 109.7, 85.3, 
60.5, 60.3, 59.9, 45.2, 38.1, 27.6, 23.2; FTIR (NaCl, thin film): 3330, 2952, 2878, 1665, 1607, 1484, 1467, 1423, 
1340, 1313, 1219, 1154, 1068 cm-1; [α]D25 = +108 (c = 0.63, CHCl3); LRMS (EI+) calc’d for [M+H]+ 360.2, 
found 360.2. 
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Pyrroloindoline 5g 
Prepared following General Procedure IV using MesDABMe and di(p-tolyl)iodonium 
triflate for 32 h. The crude residue was purified by silica gel chromatography (50% 
hexanes, 47.5% ethyl acetate, 2.5% methanol) to afford 5g as a white solid (98.2 mg, 
0.232 mmol, 77% yield). 1H NMR (500 MHz, CDCl3) δ 7.37 – 7.31 (m, 2H), 7.28 
(ddd, J = 4.7, 1.9, 1.9 Hz, 1H), 7.24 – 7.18 (m, 4H), 7.16 (d, J = 8.0 Hz, 2H), 7.11 
(ddd, J = 7.7, 7.7, 1.3 Hz, 1H), 6.93 – 6.89 (m, 1H), 6.74 (ddd, J = 7.5, 7.5, 1.0 Hz, 
1H), 6.67 (d, J = 7.8 Hz, 1H), 5.84 (d, J = 2.9 Hz, 1H), 5.56 (s, 1H), 5.43 (d, J = 2.8 Hz, 1H), 4.48 – 4.38 (m, 1H), 
4.23 (ddd, J = 10.8, 3.7, 1.3 Hz, 1H), 3.61 (dd, J = 14.5, 3.7 Hz, 1H), 3.21 (dd, J = 13.7, 7.3 Hz, 1H), 2.74 (ddd, J 
= 18.4, 14.1, 10.4 Hz, 2H), 2.33 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 168.8, 166.8, 147.1, 139.3, 137.1, 135.6, 
133.5, 129.5, 129.3, 128.9, 128.6, 127.6, 126.4, 124.1, 119.7, 109.6, 85.6, 59.0, 58.7, 56.2, 38.7, 36.3, 20.9; FTIR 
(NaCl, thin film): 3315, 3027, 2923, 2859, 1686, 1602, 1412, 1343, 1308, 1219 cm-1; [α]D25 = +208 (c = 0.61, 
CHCl3); LRMS (EI+) calc’d for [M+H]+ 424.2, found 424.2. 
 
Pyrroloindoline 5h 
Prepared following General Procedure IV using MesDABMe and di(m-tolyl)iodonium 
triflate for 4 h. The crude residue was purified by silica gel chromatography (50% 
hexanes, 47.5% ethyl acetate, 2.5% methanol) to afford 5h as a white solid (119.0 mg, 
0.280 mmol, 94% yield). 1H NMR (500 MHz, CDCl3) δ 7.33 (dd, J = 7.3, 7.3 Hz, 2H), 
7.28 (d, J = 7.3 Hz, 1H), 7.24 (d, J = 7.8 Hz, 1H), 7.20 (d, J = 7.1 Hz, 2H), 7.16 – 7.07 
(m, 4H), 6.93 (d, J = 7.4 Hz, 1H), 6.74 (dd, J = 13.8, 6.3 Hz, 1H), 6.68 (d, J = 7.8 Hz, 
1H), 5.87 (d, J = 2.9 Hz, 1H), 5.60 (s, 1H), 5.46 (d, J = 2.7 Hz, 1H), 4.49 – 4.39 (m, 1H), 4.24 (dd, J = 10.8, 2.7 
Hz, 1H), 3.61 (dd, J = 14.5, 3.7 Hz, 1H), 3.23 (dd, J = 13.7, 7.3 Hz, 1H), 2.81 – 2.68 (m, 2H), 2.34 (s, 3H); 13C 
NMR (126 MHz, CDCl3) δ 168.8, 166.8, 147.1, 142.2, 138.6, 135.6, 133.4, 129.3, 128.9, 128.7, 128.6, 128.1, 
127.6, 127.2, 124.1, 123.6, 119.6, 109.6, 85.5, 59.2, 58.7, 56.2, 38.7, 36.3, 21.6; FTIR (NaCl, thin film): 3385, 
3270, 3032, 2918, 2839, 1676, 1602, 1409, 1350, 1313, 1234, 1197 cm-1; [α]D25 = +169 (c = 0.81, CHCl3); LRMS 
(EI+) calc’d for [M+H]+ 424.2, found 424.2. 
 
Pyrroloindoline 5i 
Prepared following General Procedure IV using MesDABMe and bis(3,5-
dimethylphenyl)iodonium triflate for 4 h. The crude residue was purified by silica gel 
chromatography (50% hexanes, 47.5% ethyl acetate, 2.5% methanol) to afford 5i as a 
white solid (119.4 mg, 0.273 mmol, 91% yield). 1H NMR (500 MHz, CDCl3) 7.37 – 7.31 
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(m, 2H), 7.30 – 7.26 (m, 1H), 7.23 – 7.18 (m, 2H), 7.14 – 7.09 (m, 1H), 6.97 – 6.94 (m, 2H), 6.94 – 6.90 (m, 2H), 
6.74 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.71 – 6.65 (m, 1H), 5.88 (d, J = 2.9 Hz, 1H), 5.61 (s, 1H), 5.44 (d, J = 2.8 
Hz, 1H), 4.43 (ddd, J = 9.8, 7.1, 1.0 Hz, 1H), 4.24 (ddd, J = 10.8, 3.7, 1.4 Hz, 1H), 3.62 (dd, J = 14.5, 3.7 Hz, 
1H), 3.23 (dd, J = 13.7, 7.1 Hz, 1H), 2.77 (dd, J = 14.5, 10.8 Hz, 1H), 2.68 (dd, J = 13.7, 10.1 Hz, 1H), 2.30 (d, J 
= 0.4 Hz, 6H); 13C NMR (126 MHz, CDCl3) 168.9, 166.7, 147.1, 142.1, 138.4, 135.7, 133.5, 129.3, 129.0, 128.9, 
128.5, 127.6, 124.4, 124.1, 119.6, 109.6, 85.5, 59.1, 58.7, 56.2, 38.8, 36.3, 21.4; FTIR (NaCl, thin film): 3288, 
3051, 2919, 2854, 1684, 1604, 1484, 1455, 1418, 1346, 1312, 1255, 1204, 1156, 1109 cm-1; [α]D25 = +101 (c = 
2.0, CHCl3); LRMS (EI+) calc’d for [M+H]+ 438.2, found 438.2. 
 
Pyrroloindoline 5j 
Prepared following General Procedure IV using MesDABMe using di(p-
methoxyphenyl)iodonium triflate for 42 h. The crude residue was purified by silica gel 
chromatography (50% hexanes, 47.5% ethyl acetate, 2.5% methanol) to afford 5j as a 
white solid (88.1 mg, 0.200 mmol, 67% yield). 1H NMR (500 MHz, CDCl3) 7.36 – 7.30 
(m, 2H), 7.28 (d, J = 7.2 Hz, 1H), 7.27 – 7.23 (m, 2H), 7.20 (d, J = 7.0 Hz, 2H), 7.11 
(ddd, J = 7.7, 7.7, 1.2 Hz, 1H), 6.91 (dd, J = 7.4, 0.7 Hz, 1H), 6.89 – 6.86 (m, 2H), 6.74 
(ddd, J = 7.5, 7.5, 0.9 Hz, 1H), 6.67 (d, J = 7.8 Hz, 1H), 5.81 (s, 1H), 5.57 (s, 1H), 4.48 
– 4.40 (m, 1H), 4.24 (ddd, J = 10.8, 3.7, 1.2 Hz, 1H), 3.79 (s, 3H), 3.61 (dd, J = 14.5, 3.5 Hz, 1H), 3.18 (dd, J = 
13.7, 7.3 Hz, 1H), 2.74 (ddd, J = 20.3, 14.1, 10.4 Hz, 2H); 13C NMR (126 MHz, CDCl3) 168.9, 166.8, 158.7, 
147.1, 135.6, 134.2, 133.5, 129.3, 128.9, 128.6, 127.7, 127.6, 124.1, 119.7, 114.2, 109.7, 85.7, 58.8, 58.7, 56.2, 
55.3, 38.7, 36.3; FTIR (NaCl, thin film): 3309, 3052, 2938, 2839, 1684, 1653, 1609, 1513, 1457, 1419, 1312, 
1251, 1183, 1032 cm-1; [α]D25 = +70 (c = 0.80, CHCl3); LRMS (EI+) calc’d for [M+H]+ 440.2, found 440.2. 
 
Pyrroloindoline 5k 
Prepared following General Procedure IV using MesDABMe and (2-naphthyl)(p-
xylyl)iodonium triflate for 42 h. The crude residue was purified by silica gel 
chromatography (50% hexanes, 47.5% ethyl acetate, 2.5% methanol) to afford 5k as 
a white solid (113.0 mg, 0.246 mmol, 81% yield). 1H NMR (500 MHz, CDCl3) 7.85 
– 7.78 (m, 4H), 7.54 – 7.45 (m, 2H), 7.38 (ddd, J = 11.4, 3.9, 3.9 Hz, 1H), 7.36 – 
7.31 (m, 2H), 7.31 – 7.26 (m, 1H), 7.23 – 7.18 (m, 2H), 7.14 (ddd, J = 7.7, 7.7, 1.2 
Hz, 1H), 6.93 (dd, J = 7.4, 0.9 Hz, 1H), 6.78 – 6.68 (m, 2H), 5.98 (s, 1H), 5.59 (s, 
1H), 5.50 (s, 1H), 4.57 – 4.49 (m, 1H), 4.25 (ddd, J = 10.8, 3.7, 1.3 Hz, 1H), 3.62 (dd, J = 14.5, 3.7 Hz, 1H), 3.39 
(ddd, J = 16.0, 8.0, 8.0 Hz, 1H), 2.80 (ddd, J = 14.4, 12.1, 10.5 Hz, 2H).  13C NMR (126 MHz, CDCl3) δ 168.8, 
166.7, 147.2, 139.2, 135.6, 133.3, 133.0, 132.4, 129.3, 129.0, 128.9, 128.8, 128.0, 127.6, 127.5, 126.6, 126.4, 
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125.5, 124.3, 124.2, 119.7, 109.7, 85.4, 59.5, 58.8, 56.2, 38.5, 36.3; FTIR (NaCl, thin film): 3330, 3052, 2918, 
1676, 1605, 1483, 1409, 1343, 1303 cm-1; [α]D25 = +237 (c = 0.57, CHCl3); LRMS (EI+) calc’d for [M+H]+ 460.2, 
found 460.2. 
 
Pyrroloindoline 5l 
 
Prepared following General Procedure IV using MesDABMe and (3-bromophenyl)(p-
xylyl)iodonium triflate for 42 h. The crude residue was purified by silica gel 
chromatography (50% hexanes, 47.5% ethyl acetate, 2.5% methanol) to afford 5l as 
a white solid (79.3 mg, 0.163 mmol, 54% yield). 1H NMR (500 MHz, CDCl3) 7.48 
(dd, J = 1.8, 1.8 Hz, 1H), 7.44 – 7.39 (m, 1H), 7.33 (dd, J = 7.3, 7.3 Hz, 2H), 7.30 – 
7.25 (m, 2H), 7.24 – 7.18 (m, 3H), 7.13 (dd, J = 7.4, 7.4 Hz, 1H), 6.93 (d, J = 7.5 Hz, 1H), 6.76 (dd, J = 7.5, 7.5 
Hz, 1H), 6.69 (d, J = 7.8 Hz, 1H), 5.79 (d, J = 1.3 Hz, 1H), 5.59 (s, 1H), 5.50 (s, 1H), 4.42 (dd, J = 8.4, 8.4 Hz, 
1H), 4.25 (dd, J = 10.8, 3.0 Hz, 1H), 3.60 (dd, J = 14.5, 3.7 Hz, 1H), 3.15 (dd, J = 13.8, 7.5 Hz, 1H), 2.78 (ddd, J 
= 18.5, 14.2, 10.1 Hz, 2H); 13C NMR (126 MHz, CDCl3) 168.6, 166.9, 147.1, 144.8, 135.5, 132.5, 130.6, 130.4, 
129.6, 129.3, 129.0, 128.9, 127.6, 125.3, 124.2, 123.1, 119.9, 109.9, 85.4, 59.1, 58.5, 56.2, 38.5, 36.2; FTIR 
(NaCl, thin film): 3315, 3057, 2933, 2864, 1679, 1612, 1560, 1482, 1412, 1343, 1313, 1221 cm-1; [α]D25 = +91.4 
(c = 2.8, CHCl3); LRMS (EI+) calc’d for [M+H]+ 488.1, found 488.1. 
 
Pyrroloindoline 8 
Prepared following General Procedure IV using MesDABMe and diphenyliodonium 
triflate for 3 h. The crude residue was purified by silica gel chromatography (60% 
hexanes, 37.5% ethyl acetate, 2.5% methanol) to afford 8 as a white solid (94.6 mg, 
0.243 mmol, 81% yield). 1H NMR (500 MHz, CDCl3) 7.55 (d, J = 2.9 Hz, 1H), 7.34 – 
7.30 (m, 2H), 7.30 – 7.27 (m, 1H), 7.27 – 7.23 (m, 1H), 7.23 – 7.18 (m, 3H), 6.96 (ddd, 
J = 7.5, 7.5, 1.0 Hz, 1H), 6.73 (d, J = 7.8 Hz, 1H), 5.17 (d, J = 2.8 Hz, 1H), 4.63 (d, J = 
2.3 Hz, 1H), 4.25 (ddd, J = 12.6, 4.2, 4.2 Hz, 1H), 3.24 (dd, J = 12.6, 4.1 Hz, 1H), 3.07 (s, 3H), 2.48 (dd, J = 12.6, 
12.6 Hz, 1H); 13C NMR (126 MHz, CDCl3) 169.0, 156.9 (q, JC-F = 37.6 Hz), 148.0, 144.9, 130.1, 129.4, 128.9, 
127.5, 125.9, 125.3, 120.9, 115.5 (q, JC-F = 287.7 Hz), 110.3, 83.8, 53.4, 49.1, 35.9, 33.3; FTIR (NaCl, thin film): 
3361, 3057, 2937, 1718, 1653, 1608, 1559, 1487, 1469, 1320, 1268, 1216, 1187, 1163, 1058, 1034 cm-1; [α]D25 = 
+215 (c = 1.3, CHCl3); LRMS (EI+) calc’d for [M+H]+ 390.1, found 390.1. 
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VII.  Stereochemical Assignment of Tryptophan Arylation 
 
 
 
The stereochemical assignment of the pyrroloindole products was assigned by 1H, 13C, COSY, HSQC, HMBC, 
and NOESY 2D experiments on L-Trp-L-Phe derived pyrroloindoline 5a and assigned by spectroscopic analogy 
for pyrroloindoles 5b-f. Acyclic tryptophan-derived carboxamide 8 was independently analyzed by 1H, 13C, 
COSY, HSQC, HMBC, and NOESY 2D experiments and found to arylate from the opposite face of the prochiral 
indole moiety. Selected NOESY 2D data is included in Supporting Information 2 (Spectral Data). 
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VIII.  Total Synthesis of (+)-Naseseazines A and B 
 
Preparation of N-(2-bromo-5-iodophenyl)-2,2,2-trifluoroacetamide (SI-7) 
 
To a solution of 2-bromo-5-iodoaniline (14.9 g, 50.0 mmol, 1.0 equiv) in CH2Cl2 (250 mL) was added Et3N (10.4 
mL, 75.0 mmol, 1.50 equiv). The solution was cooled to 0 °C and trifluoroacetic anhydride (7.8 mL, 55.0 mmol, 
1.10 equiv) added dropwise by syringe. The solution was stirred for 30 minutes and slowly warmed to 23 °C and 
stirring continued for 4 hours. The reaction was then quenched by the addition of 0.5 N HCl (150 mL), and the 
reaction washed with 0.5 N HCl (2 x 100 mL). The combined organics were then back extracted with Et2O (100 
mL), and the organics dried over Na2SO4, filtered, and concentrated in vacuo to afford pure 2-bromo-5-
iodotrifluoroacetanilide as a white fluffy solid (18.8 g, 47.7 mmol, 95% yield). 1H NMR (500 MHz, CDCl3): δ 
8.63 (d, J = 2.0 Hz, 1H), 8.37 (s, 1H), 7.42 (dd, J = 8.4, 2.1 Hz, 1H), 7.29 (d, J = 8.4 Hz, 1H); 13C NMR (126 
MHz, CDCl3): δ 154.58 (q, J = 38.0 Hz), 136.2, 134.0, 133.7, 130.5, 115.3 (q, J = 288.7 Hz), 113.8, 93.0; IR 
(NaCl, thin film):  3267, 3081, 1709, 1574, 1529, 1459, 1395, 1260, 1186, 1165, 1034 cm-1; LRMS (EI+) calc’d 
for [M+H]+ 393.9, found 393.9. 
 
 
 Preparation of (3-trifluoroacetamido-4-bromophenyl)(mesityl)iodonium hexafluorophosphate (9) 
 
To a solution of 2-bromo-5-iodotrifluoroacetanilide SI-7 (11.8 g, 30.0 mmol, 1.00 equiv) in CH2Cl2 (120 mL) was 
added mCPBA (80%, 7.15 g, 33.0 mmol, 1.10 equiv). The solution was stirred for 5 minutes, then BF3•OEt2 (9.26 
mL, 75.0 mmol, 2.50 equiv) was added dropwise by syringe to afford a bright orange solution. After 45 minutes, 
the solution was cooled to 0 °C and 2,4,6-trimethylphenylboronic acid (5.41 g, 33.0 mmol, 1.10 equiv) added in a 
single portion. The mixture was stirred for an additional 15 minutes, warmed to 23 °C over 15 minutes, then 
stirred for an additional 20 minutes at room temperature.  Saturated aqueous NaPF6 (150 mL) was added to the 
solution, and the heterogeneous mixture stirred vigorously for 1 h. The solution was diluted with CH2Cl2 (100 
mL) and H2O (150 mL), the layers separated, and the aqueous layer extracted with CH2Cl2 (2 x 100 mL). The 
N
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combined organics were then dried over anhydrous Na2SO4, filtered, and concentrated in vacuo to afford a thick 
oil. The oil was co-evaporated once from Et2O (100 mL), and diluted with Et2O (500 mL). The clear supernatant 
was decanted and the residual oil co-evaporated from Et2O (200 mL), resulting in precipitation. The resulting 
solid was suspended in Et2O (500 mL) and cooled in an ice-bath for 20 minutes, then collected by vacuum 
filtration and dried under high vacuum (<1 mTorr) for 15 h to afford diaryliodonium hexafluorophosphate 10 as 
an off-white, powdery solid (14.6 g, 22.2 mmol, 74 % yield). 1H NMR (500 MHz, DMSO-d6) δ 11.53 (s, 1H), 
8.24 (d, J = 1.8 Hz, 1H), 7.91 (dd, J = 8.6, 1.9 Hz, 1H), 7.88 (d, J = 8.5 Hz, 1H), 7.27 – 7.21 (m, 2H), 2.62 (s, 
6H), 2.30 (s, 3H); 13C NMR (126 MHz, DMSO-d6) δ 155.9 (q, J = 37.6 Hz), 143.8, 142.1, 136.5 (d, J = 13.8 Hz), 
135.7 (d, J = 35.8 Hz), 130.4, 126.0, 123.4, 116.3 (q, J = 288.2 Hz), 113.2 , 26.8, 21.0; FTIR (NaCl, thin film):  
3365, 3092, 2926, 1735, 1582, 1523, 1457, 1405, 1267, 1204, 1157, 1031 cm-1; LRMS (EI+) calc’d [M–PF6]+ 
511.9, found 511.9. 
 
 
Preparation of Diketopiperazine 10 
 
 
  
To a solution of freshly prepared acid14 (SI-8) (4.75 g, 14.5 mmol, 1.00 equiv) in THF (0.4 M, 240 mL) at 
0 °C was added EDC•HCl (3.34 g, 17.4 mmol, 1.20 equiv), anhydrous HOBt (2.74 g, 20.3 mmol, 1.40 equiv) and 
Et3N (4.5 mL, 32 mmol, 2.2 equiv). The mixture was then stirred for 5 minutes, and L- proline methyl ester 
hydrochloride (2.89 g, 17.4 mmol, 1.20 equiv) was added. The reaction was slowly warmed to 23 °C over 2 hours 
and stirring continued for 20 hours. The reaction was then quenched with 1 N HCl (500 mL) and extracted with 
EtOAc (3 x 250 mL), then the combined organics washed with saturated aqueous NaHCO3 (500 mL), and 
aqueous layer back extracted with EtOAc (200 mL). The combined organic layers were then dried over anhydrous 
Na2SO4, filtered, and concentrated in vacuo to afford crude dipeptide as a viscous oil. 
 The residue was then dissolved in CH2Cl2 (100 mL), and trifluoroacetic acid (30 mL) was added 
dropwise by addition funnel at room temperature over 10 minutes. Stirring was continued for 20 minutes, then the 
solution diluted with toluene (100 mL) and the mixture concentrated in vacuo to afford a thick oil. The residue 
was then redissolved in MeOH (75 mL) and the mixture cooled to 0 °C. Et3N (55 mL) was then added dropwise 
the stirring solution over 10 minutes by addition funnel. Upon completion of the addition, the cooling bath was 
removed and the reaction was warmed to 23 °C over 1 h. After an additional 3 h at room temperature, the solution 
                                                
14 Newhouse, T., Lewis, C. A., & Baran, P. S. J. Am. Chem. Soc. 2009, 131, 6360. 
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was concentrated, the crude residue dissolved in Et2O (500 mL), and the solution washed with water (2 x 500 
mL). The organic layers were back extracted with Et2O (250 mL), and the combined organic layers washed with 
brine (200 mL), dried over anhydrous MgSO4, filtered, and concentrated in vacuo to afford a yellow oil. The 
residue was purified by silica gel flash chromatography (5% MeOH in EtOAc) to afford diketopiperazine 11 as a 
white solid (3.32 g, 10.8 mmol, 75% yield). 1H NMR (500 MHz, CDCl3) δ 6.15 (s, 1H), 4.17 – 4.10 (m, 2H), 3.65 
– 3.57 (m, 1H), 3.53 (ddd, J = 12.0, 8.9, 3.2 Hz, 1H), 3.10 (dd, J = 17.5, 3.6 Hz, 1H), 2.58 (dd, J = 17.5, 10.5 Hz, 
1H), 2.43 – 2.32 (m, 1H), 2.14 – 1.97 (m, 2H), 1.97 – 1.83 (m, 1H), 0.97 (t, J = 7.9 Hz, 9H), 0.59 (q, J = 7.9 Hz, 
6H); 13C NMR (126 MHz, CDCl3) δ 169.0, 163.9, 101.9, 86.6, 59.3, 53.9, 45.4, 28.4, 22.6, 22.5, 7.4, 4.3; FTIR 
(NaCl, thin film): 3233, 2954, 2908, 2873, 2176, 1675, 1457, 1417, 1338, 1306, 1018 cm-1; [α]D25 = –108 (c = 
0.93, CHCl3); HRMS (MM) calc’d for [M+H]+ 307.1836, found 307.1839. 
 
Preparation of Pyrroloindoline 12 
 
In a glovebox, Cu(OTf)2•PhMe (310 mg, 0.600 mmol) and tBuDABMe (1.10 g, 2.40 mmol) were added to 
an oven-dried, 200 mL round-bottomed flask. Anhydrous CH2Cl2 (60.0 mL) was then added by syringe, and the 
resulting deep-purple solution was stirred for 1 h at 25 °C in the glovebox. The solution was then filtered through 
a tight plug of cotton, and the resulting solution removed from the glovebox. 
To a flame-dried, 1-liter round-bottomed flask was charged cyclo-L-Pro-L-Trp 4f (1.50 g, 5.30 mmol, 
1.00 equiv), (4-bromo-3-trifluoroacetamidophenyl)mesityliodonium hexafluorophosphate (4.19 g, 6.36 mmol, 
1.20 equiv) in anhydrous CH2Cl2 (480 mL). The solution was stirred at 23 °C for 10 minutes, then cooled to 15 °C 
in a cold water bath. To the flask was then added the freshly prepared catalyst solution of CuI(tBuDABMe) (53.0 
mL, 1.06 mmol, 0.20 equiv) dropwise over 20 minutes. The deep-purple solution was allowed to warm to 23 °C 
over 2 hours, then stirred for 20 hours at 23 °C by which time the solution had turned to a deep red. The solution 
was then quenched by the addition of aqueous ammonium hydroxide (1.8 M, 500 mL). The mixture was 
transferred to a separatory funnel, vigorously shaken, and the layers partitioned. The aqueous layer was then back 
extracted with EtOAc (2 x 100 mL), and the combined organic layers dried over anhydrous Na2SO4, filtered, and 
concentrated in vacuo. Repeated silica gel chromatography (5% MeOH, 25% Hexanes, 70% EtOAc) afforded aryl 
pyrroloindoline 13 as an amorphous white solid (1.79 g, 3.26 mmol, 62% yield). 
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1H NMR (500 MHz, CDCl3) δ 8.47 (s, 1H), 8.42 (d, J = 2.3 Hz, 1H), 7.54 (d, J = 8.5 Hz, 1H), 7.10 (ddd, J = 7.7, 
7.7, 1.3 Hz, 1H), 7.04 (dd, J = 8.5, 2.3 Hz, 1H), 6.97 (ddd, J = 7.6, 1.2, 0.5 Hz, 1H), 6.76 (ddd, J = 7.5, 7.5, 1.0 
Hz, 1H), 6.64 (ddd, J = 7.8, 0.8, 0.8 Hz, 1H), 5.73 (s, 1H), 4.59 - 4.51 (m, 1H), 4.20 - 4.11 (m, 1H), 3.51 - 3.40 
(m, 2H), 3.09 (dd, J = 14.0, 7.9 Hz, 1H), 2.96 (dd, J = 14.0, 8.9 Hz, 1H), 2.30 (dddd, J = 12.9, 7.0, 7.0, 3.5 Hz, 
1H), 2.15 (dddd, J = 13.0, 10.5, 9.0, 7.2 Hz, 1H), 2.02 - 1.93 (m, 1H), 1.88 (ddddd, J = 17.2, 10.5, 8.6, 4.3, 4.3 
Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 168.2, 165.4, 154.8 (q, JC-F = 38.0 Hz), 147.2, 144.1, 133.5, 132.8, 132.0, 
129.0, 125.9, 124.2, 120.0, 119.9, 115.46 (q, JC-F = 288.7 Hz), 112.8, 110.0, 85.0, 60.5, 60.1, 59.8, 45.2, 38.1, 
27.5, 23.3; FTIR (NaCl, thin film): 3270, 1733, 1683, 1586, 1539, 1485, 1467, 1418, 1312, 1245, 1198, 1162 cm-
1; [α]D25 = +67.8 (c = 1.8, CHCl3); LRMS (EI+) calc’d for [M+H]+ 549.1, found 549.1. 
 
Preparation of Aniline SI-9: 
 
To a solution of pyrroloindoline 12 (150 mg, 0.273 mmol, 1.00 equiv) in EtOH at 23 °C was added NaBH4 (77.0 
mg, 2.02 mmol, 7.4 equiv). The solution was stirred vigorously for 1 h, then cooled to 0 °C and slowly quenched 
with saturated aqueous ammonium chloride (5 mL). The mixture was then diluted with H2O (50 mL) and 
extracted with EtOAc (3 x 25 mL). The combined organics were then dried over sodium sulfate, filtered, and 
concentrated under reduced pressure. Purification of the crude residue by flash silica gel chromatography (75% 
EtOAc, 20% Hexanes, 5% MeOH) afforded bromoaniline SI-9 as a white, amorphous solid (114 mg, 0.252 
mmol, 92% yield). 1H NMR (500 MHz, CDCl3) δ 7.37 (d, J = 8.3 Hz, 1H), 7.08 (ddd, J = 7.7, 7.7, 1.3 Hz, 1H), 
6.93 - 6.89 (m, 1H), 6.72 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.70 (d, J = 2.3 Hz, 1H), 6.65 - 6.58 (m, 2H), 5.76 (d, J = 
2.8 Hz, 1H), 5.35 (d, J = 3.0 Hz, 1H), 4.52 - 4.44 (m, 1H), 4.18 - 4.07 (m, 3H), 3.48 (ddd, J = 8.6, 5.2, 5.2 Hz, 
2H), 3.11 (dd, J = 13.9, 7.4 Hz, 1H), 2.76 (dd, J = 13.9, 9.7 Hz, 1H), 2.31 (dddd, J = 12.8, 7.0, 7.0, 3.3 Hz, 1H), 
2.15 (dddd, J = 12.9, 10.6, 9.2, 7.2 Hz, 1H), 2.05 - 1.96 (m, 1H), 1.95 - 1.86 (m, 1H); 13C NMR (126 MHz, 
CDCl3) δ167.9, 165.6, 147.1, 144.3, 143.0, 133.1, 132.8, 128.7, 124.1, 119.7, 117.4, 114.0, 109.6, 108.0, 85.1, 
60.5, 60.2, 59.5, 45.2, 38.0, 27.6, 23.3; FTIR (NaCl, thin film): 3457, 3341, 3003, 2953, 2881, 1661, 1612, 1572, 
1484, 1466, 1422, 1341, 1293, 1252, 1214, 1152 cm-1; [α]D25 = +118 (c = 0.80, CHCl3); LRMS (EI+) calc’d for 
[M+H]+ 453.1, found 453.1. 
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Preparation of (+)-Naseseazine B (3b) 
 
 In a glovebox, a 1-dram vial was charged with bromoaniline SI-9 (74.6 mg, 0.165 mmol, 1.00 equiv), 
alkyne 10 (127 mg, 0.412 mmol, 2.50 equiv), Na2CO3 (43.7 mg, 0.412 mmol, 2.50 equiv), and Pd[P(o-tol)3]2 (29.5 
mg, 0.0412 mmol, 25 mol %). DMF (1.70 mL) was then added and the solution stirred vigorously for 3 minutes at 
25 °C. The solution was then heated to 100 °C for 1.5 h, cooled, and concentrated under reduced pressure and 
dried under high vacuum to ensure complete removal of residual DMF. The residue was then dissolved in CH2Cl2 
(3 mL) and filtered through a plug of silica gel (50 g) to remove residual catalyst and base, then the filter cake 
rinsed (5% MeOH in CH2Cl2, 200 mL). The filtrate was then concentrated, and the crude residue dissolved in 1M 
methanolic HCl (10 mL), and stirred for 2 h at 23 °C. The solution was then concentrated and the residue was 
quenched by the addition of methanolic NH3 (1 N, 5 mL) and reconcentrated. The residue was purified by flash 
chromatography on silica gel (2 to 7% MeOH in CH2Cl2) afforded naseseazine B (3b) as a white, powdery solid 
(47.3 mg, 0.837 mmol, 51% yield). Excess TES-alkyne 10 could be recovered during chromatography. 
 
Spectroscopic and physical data, including 1H, 13C NMR in CD3OD, DMSO-d6, IR, MS, and [α]D25, obtained for 
naseseazine B matched that as reported during isolation by Raju et. al15 and data obtained by Movassaghi and 
Kim.2 See below for 1H and 13C comparison table. The use of natural amino acids in this report to synthesize (+)-
naseseazine B is in agreement with Movassaghi and Kim’s structural reassignment of the natural product.2 During 
the course of this study, we determined that the exact chemical shifts (δ) of naseseazine B observed in CD3OD 
had a slight concentration dependence. 
 
1H NMR (600 MHz, CD3OD) δ 7.56 (d, J = 8.5 Hz, 1H), 7.40 (d, J = 0.6 Hz, 1H), 7.12 (s, 1H), 7.04 (td, J 
= 7.6, 1.1 Hz, 1H), 7.00 (dd, J = 8.5, 1.1 Hz, 1H), 6.82 (dd, J = 7.2, 1.0 Hz, 1H), 6.69 – 6.64 (m, 2H), 5.82 (s, 
1H), 4.71 – 4.61 (m, 1H), 4.38 (app t, J = 4.4 Hz, 1H), 4.24 (app t, J = 8.1, 1H), 3.96 (dd, J = 9.6, 6.6 Hz, 1H), 
                                                
15 Raju, R.; Piggott, A. M.; Conte, M.; Aalbersberg, W. G. L.; Feussner, K.; Capon, R. J. Org Lett 2009, 11, 
3862. 
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3.51 – 3.36 (m, 3H), 3.30 – 3.27 (m, 2H), 3.26 – 3.21 (m, 2H), 2.57 (dd, J = 13.7, 10.1 Hz, 1H), 2.24 (dddd, J = 
10.0, 6.9, 6.9, 3.1 Hz, 1H), 2.13 – 2.03 (m, 1H), 2.00 – 1.93 (m, 2H), 1.93 – 1.84 (m, 1H), 1.72 – 1.60 (m, 1H), 
1.49 – 1.40 (m, 1H), 1.01 – 0.92 (m, 1H); 13C NMR (126 MHz, CD3OD) δ 170.8, 170.1, 168.4, 167.3, 149.1, 
137.9, 137.0, 136.0, 129.4, 127.7, 126.4, 124.9, 120.5, 119.6, 111.1, 110.4, 109.7, 86.9, 61.8, 61.7, 61.5, 60.0, 
57.1, 46.2, 45.9, 39.5, 29.2, 29.0, 28.5, 24.2, 22.6. 
 
 1H NMR (600 MHz, DMSO-d6) δ 10.80 (d, J = 2.4 Hz, 1H), 7.68 (s, 1H), 7.57 (d, J = 8.4 Hz, 1H), 7.31 (d, J = 
1.6 Hz, 1H), 7.19 (d, J = 2.4 Hz, 1H), 7.03 – 6.96 (m, 2H), 6.80 (dd, J = 7.5, 1.2 Hz, 1H), 6.75 (s, 1H), 6.61 (d, J 
= 6.6, 1 H), 6.58 (dd, J = 6.6, 1H), 5.68 (s, 1H), 4.72 (ddd, J = 9.3, 7.7, 1.3 Hz, 1H), 4.34 (ddd, J = 8.9, 7.4, 1.4 
Hz, 1H), 4.29 (app t J = 5.3 Hz, 1H), 4.06 (ddd, J = 9.9, 6.8, 1.4 Hz, 1H), 3.37 – 3.33 (m, 2H), 3.25 (ddd, J = 
12.1, 9.0, 3.9 Hz, 1H), 3.22 (dd, J = 14.9, 4.8 Hz, 1H), 3.13 (dd, J = 13.7, 7.4 Hz, 1H), 3.05 (dd, J = 14.9, 5.8 Hz, 
1H), 2.37 (dd, J = 13.7, 10.4 Hz, 1H), 2.16 (dddd, J = 12.4, 7.0, 7.0, 3.6 Hz, 1H), 2.03 - 1.91 (m, 2H), 1.90 - 1.78 
(m, 2H), 1.69 (dddd, J = 10.7, 8.7, 5.8, 2.5 Hz, 1H), 1.67 - 1.57 (m, 1H), 1.46 - 1.38 (m, 1H). 13C NMR (126 
MHz, DMSO-d6)16 δ 169.1, 167.9, 165.9, 165.5, 148.1, 135.9, 135.6, 134.6, 127.9, 126.1, 125.1, 123.4, 119.2, 
118.0, 117.9, 109.3, 109.2, 84.9, 60.0, 59.8, 59.5, 58.4, 55.2, 44.6, 38.7, 27.7, 27.1, 25.7, 23.0, 21.9. 
 
IR: 3270, 2943, 2859, 1653, 1559, 1419, 1340 cm-1; [α]D25 = +97 (c = 0.45, MeOH) LRMS (EI+) calc’d for 
[M+H]+ 565.3, found 565.3. 
Table S1. Comparison of 1H NMR data for Natural vs. Synthetic (+)-Naseseazine B 
Raju et al. Report,15 
Natural 
(+)–Naseseazine B 
1H NMR, 600 MHz, CD3OD 
This Work, 
Synthetic 
(+)–Naseseazine B 
1H NMR, 600 MHz, CD3OD 
δ 7.58 (d, J = 8.4 Hz, 1H) δ 7.56 (d, J = 8.5 Hz, 1H) 
7.41 (d, J = 1.4 Hz, 1H) 7.40 (d, J = 0.6 Hz, 1H) 
7.12 (s, 1H) 7.12 (s, 1H) 
7.06 (td, J =7.6, 1.3 Hz) 7.04 (td, J = 7.6, 1.1 Hz, 1H) 
7.03 (dd, J = 8.4, 1.8 Hz, 1H) 7.00 (dd, J = 8.5, 1.1 Hz, 1H) 
6.84 (dt, J =7.2, 0.9 Hz, 1H) 6.82 (dt, J = 7.2 Hz, 1.0 Hz, 1H), 
6.69 (t, J  = 7.6 Hz, 1H) 6.69 – 6.64 (m, 2H) 
6.68 (t, J = 7.6 Hz, 1H) – 
5.85 (s, 1H) 5.82 (s, 1H) 
4.75 (dd, J = 10.2, 8.7 Hz, 1H) 4.71 – 4.61 (m, 1H) 
4.40 (br t, J =4.7 Hz, 1H) 4.38 (app t, J = 4.4, 1H) 
4.33 (dd, J = 9.5, 7.1 Hz, 1H) 4.24 (app t, J = 8.1, 1H) 
3.99 (ddd, J = 11.4, 6.6 , 1.6 Hz, 1H) 3.96 (dd, J = 9.6, 6.6 Hz, 1H) 
3.49 (m, 1H) 3.51 – 3.36 (m, 3H) 
3.44 (m, 1H) – 
                                                
16 Movassaghi and Kim report multiple 13C resonances at 120.6 and 61.9 (CD3OD). See reference (2) of Supporting Information. 
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3.44 (m, 1H) – 
3.32 (m, 1H) 3.30 – 3.27 (m, 2H) 
3.28 (m, 1H) – 
3.27 (m, 1H) 3.26 – 3.21 (m, 2H) 
3.24 (m, 1H) – 
2.59 (dd, J = 13.8, 10.2 Hz, 1H) 2.57 (dd, J = 13.7, 10.1 Hz, 1H) 
2.28 (m, 1H) 2.24 (dddd, J = 10.0, 6.9, 6.9, 3.1 Hz, 1H) 
2.11 (m, 1H) 2.13 – 2.03 (m, 1H) 
2.00 (m, 1H) 2.00 – 1.93 (m, 2H) 
1.97 (m, 1H) – 
1.95 (m, 1H) 1.93 – 1.84 (m, 1H) 
1.67 (m, 1H) 1.72 – 1.60 (m, 1H) 
1.44 (m, 1H) 1.49 – 1.40 (m, 1H) 
0.92 (m, 1H) 1.01 – 0.92 (m, 1H) 
 
Table S2. Comparison of 13C NMR data for Natural vs. Synthetic (+)-Naseseazine B 
Raju et al. Report,15 
Natural 
(+)–Naseseazine B 
13C NMR, 151 MHz, CD3OD 
This Work, 
Synthetic 
(+)–Naseseazine B 
13C NMR, 126 MHz, CD3OD 
Chemical Shift Difference, Δδ 
δ 170.7 δ 170.8 0.1 
170.2 170.1 0.1 
168.4 168.4 0.0 
167.3 167.3 0.0 
149.0 149.1 0.1 
137.9 137.9 0.0 
136.9 137.0 0.1 
136.0 136.0 0.0 
129.1 129.4 0.3 
127.6 127.7 0.1 
126.1 126.4 0.3 
124.8 124.9 0.1 
120.3 120.5 0.2 
120.3 –17 – 
119.4 119.6 0.2 
111.0 111.1 0.1 
110.3 110.4 0.1 
109.5 109.4 0.1 
86.8 86.9 0.1 
61.8 61.8 0.0 
61.7 61.7 0.0 
61.3 61.5 0.2 
59.9 60.0 0.1 
57 57.1 0.1 
45.9 46.2 0.3 
                                                
17 Raju et. al report two resonances at 120.3. The spectrum acquired in this report (126 MHz) only contains a single visible peak at 120.5 
due to overlap. 
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45.8 45.9 0.1 
39.5 39.5 0.0 
29.2 29.2 0.0 
29.1 29.0 0.1 
28.3 28.5 0.2 
24.1 24.2 0.1 
22.4 22.6 0.2 
 
 
Preparation of Pyrroloindoline 13 
 
In a glovebox, Cu(OTf)2•PhMe  (77.6 mg 0.150 mmol) and tBuDABMe (277 mg, 0.600 mmol, 2.40 mmol) 
were added to an oven-dried, 50 mL round-bottomed flask. Anhydrous CH2Cl2 (27.0 mL) was then added by 
syringe, and the resulting deep-purple solution was stirred for 1 h at 25 °C in the glovebox. The solution was then 
filtered through a tight plug of cotton, and the resulting solution removed from the glovebox. 
To a flame-dried, 100-mL round-bottomed flask was charged cyclo-L-Ala-L-Trp 4f (334 mg, 1.30 mmol, 
1.00 equiv) and (4-bromo-3-trifluoroacetamidophenyl)mesityliodonium hexafluorophosphate (940 mg, 1.43 
mmol, 1.10 equiv)). To the flask was then added the freshly prepared catalyst solution of CuI(tBuDABMe) (26.0 
mL, 0.260 mmol, 0.20 equiv) dropwise over 20 minutes. The deep-purple solution was allowed to warm to 23 °C 
over 2 hours, then stirred for 8 hours at 23 °C. The solution was then quenched by the addition of aqueous 
ammonium hydroxide (1.8 M, 20 mL). The mixture was then diluted with EtOAc (100 mL), transferred to a 
separatory funnel, vigorously shaken, and the layers partitioned. The aqueous layer was then back-extracted with 
EtOAc (2 x 100 mL), and the combined organic layers dried over anhydrous Na2SO4, filtered, and concentrated in 
vacuo. Silica gel flash chromatography (78% EtOAc, 20% hexanes, 2 % MeOH) afforded aryl pyrroloindoline 12 
as a white solid (402.0 mg, 0.767 mmol, 59% yield). 1H NMR (500 MHz, CDCl3) δ 8.51 (s, 1H), 8.39 (d, J = 2.3 
Hz, 1H), 7.53 (d, J = 8.5 Hz, 1H), 7.20 (s, 1H), 7.09 (ddd, J = 7.7, 7.7, 1.0 Hz, 1H), 7.03 (dd, J = 8.5, 2.3 Hz, 1H), 
6.95 (d, J = 7.4 Hz, 1H), 6.73 (dd, J = 7.5, 7.5 Hz, 1H), 6.64 (d, J = 7.9 Hz, 1H), 5.73 (s, 1H), 5.68 (br s, 1H), 
4.47 (dd, J = 8.3, 8.3 Hz, 1H), 4.10 – 4.03 (m, 1H), 3.09 (dd, J = 13.9, 7.9 Hz, 1H), 2.89 (dd, J = 13.9, 8.9 Hz, 
1H), 1.41 (d, J = 6.9 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 169.8, 168.4, 154.8 (q, JC-F = 38.0 Hz) 147.3, 144.0, 
133.4, 132.8, 131.9, 129.0, 125.9, 124.0, 120.0, 119.7, 115.4 (q, JC-F = 288.6 Hz) 113.0, 110.1, 85.1, 59.3, 58.7, 
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51.2, 38.2, 15.2; FTIR (NaCl, thin film): 3270, 1733, 1683, 1586, 1539, 1485, 1467, 1418, 1312, 1245, 1198, 
1162 cm-1; [α]D25 = +84 (c = 0.42, CHCl3); LRMS (EI+) calc’d for [M+H]+ 523.1, found 523.1. 
 
Preparation of Aniline SI-10 
 
To a solution of pyrroloindoline 12 (140 mg, 0.268 mmol, 1.00 equiv) in EtOH (5.4 mL) at 23 °C was 
added NaBH4 (76.3 mg, 2.00 mmol, 7.5 equiv). The solution was stirred vigorously for 1 h, then cooled to 0 °C 
and slowly quenched with saturated aqueous ammonium chloride (5 mL). The mixture was then diluted with H2O 
(50 mL) and extracted with EtOAc (3 x 45 mL). The combined organics were then dried over sodium sulfate, 
filtered, and concentrated in vacuo. Purification of the crude residue by flash silica gel chromatography (75% 
EtOAc, 20% Hexanes, 5% MeOH) afforded bromoaniline SI-10 as a white, amorphous solid (94.0 mg, 0.220 
mmol, 82% yield). 1H NMR (500 MHz, CDCl3) δ 7.31 (d, J = 8.4 Hz, 1H), 7.04 (ddd, J = 7.6, 7.6, 1.3 Hz, 1H), 
6.91 - 6.85 (m, 1H), 6.85 (d, J = 2.3 Hz, 1H), 6.67 (ddd, J = 19.2, 7.7, 1.0 Hz, 2H), 6.56 (dd, J = 8.4, 2.4 Hz, 1H), 
5.72 (s, 1H), 4.56 (ddd, J = 10.0, 7.4, 1.6 Hz, 1H), 4.14 (qd, J = 6.8, 1.5 Hz, 1H), 3.10 (ddd, J = 14.0, 7.5, 1.7 Hz, 
1H), 2.52 (dd, J = 13.6, 9.9 Hz, 1H), 1.37 (d, J = 6.9 Hz, 2H); FTIR (NaCl, thin film): 3345, 2919, 1668, 1605, 
1483, 1418, 1300, 1209 cm-1; [α]D25 = +156 (c = 0.38, MeOH); LRMS (EI+) calc’d for [M+H]+ 427.1, found 
427.1. 
Preparation of (+)-Naseseazine A (3a) 
 
 In a glovebox, a 1-dram vial was charged with bromoaniline SI-10 (79.8 mg, 0.187 mmol, 1.00 equiv), 
alkyne 10 (143 mg, 0.467 mmol, 2.50 equiv), Na2CO3 (49.5 mg, 0.467 mmol, 2.50 equiv), and Pd[P(o-tol)3]2 (33.4 
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mg, 0.0467 mmol, 25 mol %). DMF (1.90 mL) was then added and the solution stirred vigorously for 3 minutes at 
25 °C. The solution was then heated to 100 °C for 1 h, cooled, and concentrated under reduced pressure and dried 
under high vacuum to ensure complete removal of residual DMF. The residue was then dissolved in CH2Cl2 (3 
mL) and filtered through a plug of silica gel (50 g) to remove residual catalyst and base, then the filter cake rinsed 
(6% MeOH in CH2Cl2, 260 mL). The filtrate was then concentrated, and the crude residue dissolved in 1M 
methanolic HCl (12 mL), and stirred for 2 h at 23 °C. The solution was then concentrated and the residue was 
quenched by the addition of methanolic NH3 (1 N, 12 mL) and reconcentrated. The residue was purified by flash 
chromatography on silica gel (2 to 10% MeOH in CH2Cl2) afforded (+)-naseseazine A (3b) as a white, powdery 
solid (56.5 mg, 0.105 mmol, 56% yield). Excess TES-alkyne 10 could be recovered during chromatography.  
 
Spectroscopic and physical data, including 1H, 13C NMR in CD3OD, DMSO-d6, IR, MS, and [α]D25, obtained for 
naseseazine A matched that as reported during isolation by Raju et. al15 and data obtained by Movassaghi and 
Kim.2 See below for 1H and 13C comparison table. The use of natural amino acids in this report to synthesize (+)-
naseseazine A is in agreement with Movassaghi and Kim’s structural reassignment of the natural product.2 During 
the course of this study, we determined that the exact chemical shifts (δ) of naseseazine A observed in CD3OD 
had a slight concentration dependence. 
 
1H NMR (600 MHz, CD3OD) δ 7.55 (d, J = 8.4 Hz, 1H), 7.38 (s, 1H), 7.11 (s, 1H), 7.04 (app t, J = 7.6 Hz, 1H), 
7.00 (d, J = 8.4 Hz, 1H), 6.83 (d, J = 7.4 Hz, 1H), 6.70 – 6.62 (m, 2H), 5.80 (s, 1H), 4.58 (app t, J = 8.6 Hz, 1H), 
4.37 (dd, J = 4.7, 4.7 Hz, 1H), 4.10 (q, J = 6.8 Hz, 1H), 3.95 (dd, J = 10.7, 6.5 Hz, 1H), 3.41 (dt, J = 11.8, 8.3 Hz, 
1H), 3.29 – 3.25 (m, 3H), 3.23 (dd, J = 13.2, 7.8 Hz, 2H), 2.58 (dd, J = 13.5, 10.0 Hz, 1H), 2.00 – 1.91 (m, 1H), 
1.71 – 1.60 (m, 1H), 1.48 – 1.40 (m, 1H), 1.36 (d, J = 6.8 Hz, 3H), 1.01 – 0.91 (m, 1H); 13C NMR (126 MHz, 
CD3OD) δ 172.5, 170.8, 170.7, 167.3, 149.1, 137.9, 137.2, 135.9, 129.4, 127.6, 126.4, 125.0, 120.5, 120.4, 119.6, 
111.1, 110.3, 109.7, 87.1, 61.2, 60.3, 60.0, 57.1, 52.2, 45.9, 39.7, 29.2, 29.0, 22.6, 15.3. 
 
 1H NMR (600 MHz, DMSO-d6) δ 10.80 (s, 1H), 8.18 (s, 1H), 7.68 (s, 1H), 7.57 (d, J = 8.4 Hz, 1H), 7.29 (s, 1H), 
7.19 (s, 1H), 7.01 – 6.96 (m, 2H), 6.83 (d, J = 7.3 Hz, 1H), 6.73 (s, 1H), 6.65 – 6.54 (m, 2H), 5.66 (s, 1H), 4.61 
(dd, J = 8.6, 8.6 Hz, 1H), 4.28 (dd, J = 4.6, 4.6 Hz, 1H), 4.14 (q, J = 6.7 Hz, 1H), 4.10 – 4.03 (m, 1H), 3.40 – 3.35 
(m, 1H), 3.28 – 3.18 (m, 2H), 3.07 (ddd, J = 26.8, 14.2, 6.7 Hz, 2H), 2.42 (dd, J = 13.1, 10.3 Hz, 1H), 2.02 – 1.93 
(m, 1H), 1.70 (ddd, J = 27.0, 9.2, 9.2 Hz, 1H), 1.65 – 1.56 (m, 1H), 1.48 – 1.37 (m, 1H), 1.23 (d, J = 6.8 Hz, 3H). 
13C NMR (126 MHz, DMSO-d6) δ 170.0, 169.1, 168.6, 165.5, 148.1, 135.9, 135.7, 134.4, 127.9, 126.1, 125.0, 
123.6, 119.1, 117.9, 117.8, 109.3, 109.2, 109.1, 85.0, 59.3, 58.4, 58.4, 55.2, 50.3, 44.6, 38.8, 27.7, 25.7, 21.9, 
14.8. 
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FTIR: 3306, 2913, 2859, 1668, 1449, 1418, 1343, 1308 cm-1; [α]D25 = +121 (c = 0.30, MeOH); LRMS (EI+) 
calc’d for [M+H]+ 539.2, found 539.2.  
 
Table S3. Comparison of 1H NMR data for Natural vs. Synthetic (+)-Naseseazine A 
Raju et al. Report,15 
(+)–Naseseazine A 
1H NMR, 600 MHz, CD3OD 
This Work 
(+)–Naseseazine A 
1H NMR, 600 MHz, CD3OD 
δ 7.57 (d, J = 8.4 Hz, 1H) δ 7.55 (d, J = 8.4 Hz, 1H) 
7.40 (s, 1H) 7.38 (s, 1H) 
7.11 (s, 1H) 7.11 (s, 1H) 
7.05 (t, 7.2 Hz, 1H) 7.04 (app t, J = 7.6 Hz, 1H) 
7.02 (d, J = 8.4 Hz, 1H) 7.00 (d, J = 8.4 Hz, 1H) 
6.85 (d, J = 7.4 Hz, 1H) 6.83 (d, J = 7.4 Hz, 1H) 
6.69 (d, J = 7.6 Hz, 1H) 6.70 – 6.62 (m, 2H) 
6.67 (t, J = 8.5 Hz, 1H) – 
5.83 (s, 1H) 5.80 (s, 1H) 
4.64 (dd, J = 8.4, 7.4 Hz, 1H) 4.58 (app t, J = 8.6 Hz, 1H) 
4.39 (br t, J = 4.5 Hz, 1H) 4.37 (dd, J = 4.7, 4.7 Hz, 1H) 
4.15 (q, J = 6.9 Hz, 1H) 4.10 (q, J = 6.8 Hz, 1H) 
3.97 (dd, J = 10.8, 6.6 Hz, 1H) 3.95 (dd, J = 10.7, 6.5 Hz, 1H 
3.42 (dt, J = 11.8, 8.1 Hz, 1H) 3.41 (dt, J = 11.8, 8.3 Hz, 1H) 
3.30 (m, 1H) 3.29 – 3.25 (m, 3H) 
3.29 (m, 1H) – 
3.26 (m, 1H) – 
3.24 (m, 1H) 3.23 (dd, J = 13.2, 7.8 Hz, 2H) 
2.59 (dd, J  = 13.7, 10.2 Hz, 1H) 2.58 (dd, J = 13.5, 10.0 Hz, 1H) 
1.97 (m, 1H) 2.00 – 1.91 (m, 1H) 
1.66 (m, 1H) 1.71 – 1.60 (m, 1H) 
1.43 (m, 1H) 1.48 – 1.40 (m, 1H) 
1.38 (d, J = 6.9 Hz, 1H) 1.36 (d, J = 6.8 Hz, 3H) 
0.93 (m, 1H) 1.01 – 0.91 (m, 1H) 
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Table S4. Comparison of 13C NMR data for Natural vs. Synthetic (+)-Naseseazine A 
Raju et al. Report,15 
(+)–Naseseazine A 
13C NMR, 151 MHz, CD3OD 
This Work 
(+)–Naseseazine A 
13C NMR, 126 MHz, CD3OD 
Chemical Shift Difference, Δδ 
172.6 172.5 0.1 
170.6 170.8 0.2 
170.6 170.7 0.1 
167.3 167.3 0.0 
149.1 149.1 0.0 
137.9 137.9 0.0 
137.2 137.2 0.0 
135.8 135.9 0.1 
129.2 129.4 0.2 
127.6 127.6 0.0 
126.2 126.4 0.2 
124.9 125.0 0.1 
120.3 120.5 0.2 
120.2 120.4 0.2 
119.5 119.6 0.1 
110.9 111.1 0.2 
110.1 110.3 0.2 
109.5 109.7 0.2 
87.1 87.1 0.0 
61.2 61.2 0.0 
60.2 60.3 0.1 
60.0 60.0 0.0 
57.2 57.1 0.1 
52.1 52.2 0.1 
45.8 45.9 0.1 
39.7 39.7 0.0 
29.0 29.2 0.2 
29.0 29.0 0.0 
22.5 22.6 0.1 
15.2 15.3 0.1 
 
                                                
 
